The research group at Drew University (USA) and others published a study titled “From Bench to Bedside: The Growing Use of Arabinoxylan Rice Bran (MGN-3/Biobran) in Cancer Immunotherapy”. This study was published in Austin Immunology – Volume 1 Issue 2.